Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation

Keyphrases

• Acute Lung Inflammation 100%
• PARP Inhibitor (PARPi) 100%
• Lipopolysaccharide-induced 100%
• Chemokines 20%
• Lipid Peroxidation 20%
• Neutrophil Accumulation 20%
• Lung Inflammation 20%
• Pharmacological Inhibitors 20%
• Lipopolysaccharide 20%
• PJ34 20%
• Lung 10%
• MIP-2 10%
• Interleukin-6 10%
• Myeloperoxidase Activity 10%
• Nitrate 10%
• Malondialdehyde 10%
• Pulmonary Inflammation 10%
• Interleukin-1β 10%
• Permeability Edema 10%
• Dual Approach 10%
• Cytokine TNF-α 10%
• Protein Content 10%
• Balb C Mice 10%
• Lung Tissue 10%
• Histological Analysis 10%
• DNA Damage 10%
• Lung Damage 10%
• Phenanthridinones 10%
• Hyperpermeability 10%
• Leukocyte Count 10%
• Mechanistic Role 10%
• Similarity Experiment 10%
• High Permeability 10%
• NO Production 10%
• Nitric Oxide Production 10%
• Clinical Conditions 10%
• Nitrite 10%
• Oxidative Stress 10%
• Intratracheal Instillation 10%
• Genomic Deletion 10%
• Tissue Injury 10%
• MIP-1b 10%
• Bronchoalveolar Lavage 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Lipopolysaccharide-Induced Lung Inflammation 100%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1 100%
• Lipopolysaccharide 37%
• Chemokine 25%
• Cytokine 25%
• Tissue Injury 12%
• Malonaldehyde 12%
• Myeloperoxidase 12%
• Interleukin 6 12%
• Tumor Necrosis Factor 12%
• Oxidizing Agent 12%
• Edema 12%
• Nitrite 12%
• Nitric Oxide 12%
• Interleukin 1beta 12%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor 12%
• Bagg Albino Mouse 12%